Too Little Too Late? Pfizer, Moderna to Study Long-Term Risk of Myocarditis After COVID Vaccines by Suzanne Burdick, Ph.D. for Children’s Health Defense
Pfizer and Moderna are launching clinical trials to track long-term health issues following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults, but some experts said the risks are already clear.
Pfizer and Moderna are launching clinical trials to track long-term health issues following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults.
Myocarditis and pericarditis are heart problems that multiple medical studies have shown to be associated with mRNA COVID-19 vaccination, particularly among young men.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
Studies also show that the risk of myocarditis — which can cause permanent damage to heart muscle — increases with the number of boosters a person has taken and can in some cases cause death.
Health officials contacted by NBC News did not suggest that official guidance on COVID-19 vaccination will change while the studies of long-term health issues from vaccine-related heart problems are underway.
The U.S. Food and Drug Administration (FDA) declined to comment on Pfizer’s and Moderna’s studies, but an agency official told NBC News the chance of having myocarditis occur following vaccination is “very low.”
Too little, too late?
Commenting on the news, Dr. Peter McCullough — internist, epidemiologist, cardiologist and leading expert on COVID-19 treatment — said in a Nov. 16 Substack post:
“Now two years after public release and mounting cases of fatal myocarditis published in the peer-reviewed literature, both Pfizer and Moderna have announced they will begin studies of cardiac safety that the FDA required in their 2021 Biological Licensing Agreement letters from the FDA.”
“Why did the US government and the vaccine companies wait so long? Do they anticipate their own bad news will kill the failing product line?”
McCullough, who authored “The Courage to Face COVID-19” and developed the McCullough Protocol for early treatment of COVID-19, said only an internal document review from government agencies and vaccine developers will tell the public what was going on during this “biological product safety disaster.”
“As a cardiologist, I can tell you the entire discipline of cardiovascular disease is oriented to preserving heart tissue. Heart muscle is largely terminally differentiated with low rates of turnover; hence, we cannot afford to lose any cardiomyocytes to damage caused by vaccines.”
McCullough listed a number of studies on how the mRNA vaccines affect the heart:
